Repositorio Dspace

02.01. Área de Salud I Murcia Oeste

02.01. Área de Salud I Murcia Oeste

Envíos recientes

  • Ruiz-Lorente, Inmaculada; Vallejo-Pulido, Andres; López-Abad, Alicia; López-Cubillana, Pedro; Barozi, Victor; Khakoo, Salim-I.; Minguela-Puras, Alfredo; Gimeno-Arias, Lourdes (TAYLOR & FRANCIS INC, 2026-12-31)
    BACKGROUND: Rates of cancer cure increase; however, recurrence and refractoriness remain clinical challenges that require alternative therapeutic strategies. Natural killer (NK) cells could play a decisive role if their ...
  • Camacho, Juan; García-ibanez, Nerea; Fernández-García, María-Dolores; Biya, Yasmin; Ruiz-de-Pedro, Estrella; Gutierrez, Almudena; Nieto, María-Carmen; Ruiz-García, María-Montserrat; Pastor-Fajardo, María-Teresa; Lagarejos, Eduardo; de-Leonardo-Simon, Carlos; Navascues, Ana; Moreno-Docón, Antonio; Gozalo-marguello, Monica; Berengua, Carla; Antequera, Pedro; Huéscar-Pascual, María-Dolores; Calvo, Cristina; Cabrerizo, María (WILEY, 2026-04)
    Enterovirus D68 (EV-D68) is a significant cause of respiratory and neurological disease worldwide. In 2024, Spain experienced its largest recorded EV-D68 outbreak, accounting for 37.4% of all typed EV (294/892). This study ...
  • Aldamiz-Echevarria, Teresa; Tejerina, Francisco; Fanciulli, Chiara; Díez, Cristina; Pérez, Leire; Bellon, José-María; Espinosa, Nuria; Guillen, Santiago-Moreno; del-Mar-Arcos-Rueda, María; Montero-Alonso, Marta; García-Fraile, Lucio; Asensi, Victor; Fernández-López, Marian; Corona-Mata, Diana; Cabello-Ubeda, Alfonso; Manso, Meritxell-Gavalda; Iribarren, José-Antonio; Pérez-Martínez, Laura; Valls, María-Remedios-Aleman; Portilla-Tamarit, Irene; Peraire, Joaquim; Suarez-García, Ines; Masia, Mar; Núñez-Orantos, María-José; Gutiérrrez-Liarte, Ángela; Imaz, Arkaitz; Hernández-Gutierrez, Cristina; Pitarch, María-Tasias; Rava, Marta (WILEY, 2026-08)
    OBJECTIVES: Lymphomas remain among the most frequent HIV-associated malignancies, with risk persisting despite effective virological control. This study describes the clinical, epidemiological and prognostic characteristics ...
  • García-Villalba, Julio; Hurtado-Navarro, Laura; Angosto-Bazarra, Diego; Baroja-Mazo, Alberto; Pelegrín, Pablo (WILEY, 2026-04)
    Inflammasomes orchestrate the inflammatory response against bacterial and viral infections, thereby initiating the synthesis of pro-inflammatory cytokines, mainly IL-1? and IL-18. SARS-CoV-2 infection induces an inflammatory ...
  • Ortega-García, Juan-Antonio; Tarbal-Roquer, Arian; Díaz-Martínez, Francisco; Codina-Sampera, Elena; Orenes-Piñero, Esteban (Springer Science and Business Media LLC, 2026-08-13)
    BACKGROUND: Parkinson's disease (PD) is a progressive neurodegenerative disorder in which environmental exposures, particularly pesticides, are increasingly recognized as relevant risk factors. Chronic occupational pesticide ...
  • Hennermann, Julia-B.; Guffon, Nathalie; Thomas, Sophie; Stepien, Karolina-M.; Lampe, Christina; Muschol, Nicole-M.; Ballesta-Martínez, María-Juliana; Cruz, Jordi; López-Rodríguez, Monica; Barth, Anneliese; Lund, Allan-M.; Plaiasu, Vasilica; Donati, Chiara; Morgan, Heather-M.; Ballabeni, Andrea; Magner, Martin (BMC, 2026-07-22)
    BACKGROUND: This study assessed quality of life (QoL) changes over time amongst caregivers of patients with alpha-mannosidosis, a rare autosomal recessive lysosomal storage disorder with progressive multi-systemic effects. ...
  • Carmona-Bayonas, Alberto; Jiménez-Fonseca, Paula; Capdevila, Jaume; Alonso, Vicente; Benavent, Marta; López-López, Carlos; Ruffinelli, José-Carlos; Crespo, Guillermo; Nosti, Laura; San-Roman-Gil, María; Marín-Zafra, Gema-Rocío; Hernando, Jorge; Azpiroz, Mónica-Marazuela; Castano, Angel; García-Carbonero, Rocio (ELSEVIER SCI LTD, 2026-11)
    BACKGROUND: In resected stage I-III gastroenteropancreatic neuroendocrine carcinomas (GEP-NEC), whether perioperative chemotherapy eradicates residual disease or merely delays relapse is unknown, since Cox models cannot ...
  • Martin-Moro, Fernando; Muntanola, Ana; Gutiérrez, Xabier; Vázquez, María-Sofia; Morais, Lucía; Amarika, Itxaso; Diez-Feijoo, Ramon; Bastos-Oreiro, Mariana; de-la-Cruz, Beatriz; Marco-Ayala, Javier; Ramos, Sergio; Jiménez-Ubieto, Ana; Galindo-Navarro, Pablo; Correa, Juan-Gonzalo; Lavilla, Esperanza; García-Herce, Cristina; Moreno, Miriam; Domingo-Domenech, Eva; Domínguez, Nazaret; Alonso, Aranzazu; Otero, María-José; Comai, Alessandra; Bengochea, María-Luisa; Da-Ros, Carolina-Villegas; Gutiérrez, Norma-C; Lluch, Rafael; Fernández-Luis, Sara; Soler, Joan-Alfons; Cannata-Ortiz, M-Jimena; Medina, Ángeles; Martin-Consuegra, Sofia; Aceituno, Marta; Villafuerte, Paola; de-Miguel, Dunia; Arguinano, José-María; López, Javier; Villalon, Lucía; Gulino, Horacio; López-Guillermo, Armando; Salar, Antonio (ELSEVIER, 2026-10-27)
    There is no established standard treatment of relapsed/refractory (R/R) marginal zone lymphoma (MZL). Zanubrutinib was approved in this setting based on the phase 2 MAGNOLIA trial. We retrospectively evaluated the ...
  • Gil, José-Vicente; Sargas, Claudia; Ayala, Rosa; Gutiérrez, Norma-Carmen; Pérez-Simon, José-Antonio; Gómez-Casares, María-Teresa; Larrayoz, María-José; Prados, Esther; Cano-Ferri, Isabel; Navarro, Irene; Gil, Cristina; Bernal, Teresa; Rodríguez-Arboli, Eduardo; Pérez-Santaolalla, Esther; Colmenares, Rafael; Tormo, Mar; Bergua, Juan; Amigo, María-Luz; Rodríguez-Medina, Carlos; Serrano, Josefina; Oliva, Ana-Yurena; Alonso-Domínguez, Juan-Manuel; Noriega, Victor; Algarra, Lorenzo; Olave, Mayte; García-Pérez, María-José; Couto, Carmen; Almela, Agata; García-Fortes, María; Madrigal, María-Dolores; Hermosin, María-Lourdes; Colorado, Mercedes; García-Boyero, Raimundo; Ibanez, Francisco; Sole, María; Martínez-Chamorro, Carmen; Mateos, María-del-Carmen; García-Garay, María-Carmen; Solana-Altabella, Antonio; Martin-Herreros, Beatriz; Martínez-López, Joaquin; Chillon, María-del-Carmen; Soria, Elena; Bilbao-Syeiro, Cristina; Calasanz, María-José; Sánchez-García, Joaquin; Barragan, Eva; Montesinos, Pau (ELSEVIER, 2026-10-08)
    NPM1-mutated acute myeloid leukemia (AML) is genetically well defined, but clinical outcomes remain heterogeneous, suggesting that quantitative clonal features may refine current risk stratification. We analyzed 688 ...
  • Sánchez-Villalobos, María; Campos-Baños, Eulalia; Martínez-Balsalobre, Elena; Pinilla-Marquínez, Miriam; Navarro-Ramírez, Verónica; Macartney, Thomas; Hurtado-Navarro, Laura; Hernández-García, David; Blanquer-Blanquer, Miguel; Pelegrín, Pablo; Salido-Fiérrez, Eduardo-José; Pérez-Oliva, Ana-Belén (MDPI AG, 2026-09-15)
    Inflammasomes play a pivotal role in inflammation and infection, but the clinical relevance of inflammasomes goes beyond infectious disease. Here, we report a novel variant in the NLRP1 gene (p.V939M) identified in a patient ...
  • Gázquez, Antonio; Origüela-Carvajal, Valentina; Prieto-Sánchez, María-Teresa; Blanco-Carnero, José-Eliseo; Larque, Elvira (ELSEVIER BV, 2026-10)
    Myo-inositol (MI) is a precursor of inositol-3-phosphate, which participates in the insulin receptor pathway. Glucose enhances urinary MI excretion, which could affect gestational diabetes mellitus (GDM) management. The ...
  • Romero-Murillo, Silvia; Peris, Irene; Luciano, Anna-María; Marcotegui, Nerea; Vicente, Carmen; Tran, Brian; Barrie, Kelsey; O'Connor, Caitlin-M; Torres-López, Andrea; Mateos, María-C; Cayuela-Fuentes, María-Luisa; Mulero, Victoriano; Fernández-Irigoyen, Joaquin; Santamaria, Enrique; Odero, María-D; Narla, Goutham (AMER SOC CLINICAL INVESTIGATION INC, 2026-10-22)
    Cell metabolic rewiring is associated with resistance to venetoclax-azacitidine (Ven-Aza) combination therapy and relapse in patients with acute myeloid leukemia (AML). Drug-resistant cells exhibit an enhanced reliance on ...
  • Herranz-Antolin, Sandra; Martínez-Brocca, María-Asuncion; Canovas-Molina, Gloria; Aragón-Alonso, Aurora; Brito-Sanfiel, Miguel; Martínez-Montoro, José-Ignacio; Bellido, Virginia; Azriel, Sharona; López-García, María-del-Carmen; Tejera, Cristina; Bartual, Amparo; Perea, Veronica; Pines, Pedro-José; Amor, Antonio-J; Moreno-Pérez, Oscar; Reyes-García, Rebeca; López-Gallardo, Gema; Duran-Martínez, María; Serrano, Cristina; Marquez-Pardo, Rosa; de-Villar, Noemi-González-Pérez; Gargallo, Manuel; Santos, Estefania; Pujante, Pedro; Ares, Jessica; Bellido, Diego; Conget, Ignacio; Gómez-Peralta, Fernando (WILEY, 2026-10-15)
    Objective To clarify whether the glucose management indicator (GMI)/glycated haemoglobin (HbA1c) ratio (GMI/HbA1c ratio) is an independent predictor of microvascular complications in Type 1 diabetes (T1D). Design and Methods ...
  • Sánchez-García, Carmen-María; Valero-López, Ángel; Hernández-Clares, Rocío; Sánchez-García, Carmen-María (ELSEVIER ESPANA SLU, 2026-10)
  • Reardon, Patrick; Zhong, Michael; Horakova, Dana; Kermode, Allan-G; Fabis-Pedrini, Marzena; Vachova, Marta; Prevost, Julie; Lechner-Scott, Jeannette; van-der-Walt, Anneke; Pavelek, Zbysek; Stourac, Pavel; Stetkarova, Ivana; Meca-Lallana, José-Eustasio; McCombe, Pamela; Gross-Paju, Katrin; Millan-Pascual, Jorge; Kalincik, Tomas; Roos, Izanne; Lapointe, Emmanuelle; Houskova, Jana; Recmanova, Eva; Peterka, Marek; Ampapa, Radek; Jakob, Gregor-Brecl; Foschi, Matteo; Jokubaitis, Vilija; Butzkueven, Helmut (ELSEVIER SCI LTD, 2026-11)
    INTRODUCTION: Ofatumumab (OFA) is an emerging therapy for relapsing-remitting multiple sclerosis (RRMS), but the impact of prior disease-modifying therapy (pDMT) on outcomes after switching is unclear. OBJECTIVES: To ...
  • de-los-Santos, Ignacio; Pousada, Guillermo; Galera-Peñaranda, Carlos; Duenas, Carlos; Buzon, Luis; Sanz, José; Martin, Cristina; Garcinuno, María-Ángeles; Galindo, María-José; García-Fraile, Lucio; Pedrero-Tome, Roberto; Troya, Jesús (SAGE PUBLICATIONS INC, 2026-01)
    IntroductionLow-level viraemia (LLV) in people living with HIV (PLWH) remains a clinical challenge, associated with increased risk of virological failure, immune dysregulation, and chronic inflammation. Bictegravir/emtri ...
  • Beatriz, Ruth-Gloria; Domínguez-Ortega, Gloria; Espin-Jaimed, Beatriz; Fernández-Fernándeze, Sonia; Vila-Miravetf, Victor; Gonzalo-Consuegrag, Julia; Carabano-Aguadoh, Ivan; García-Diaze, Alejandro; Torres-Perali, Ricardo; Arcos-Machancosesg, José-Vicente; Grande-Herrerok, Luis; Rodríguez-Jiménezk, Cristina; Escartin-Madurgal, Laura; Pérez-Moneom, Begona; Gil-Ortega, David; Di-Campli-Zaghlul, Mariana; Bordonaba-Bosque, Daniel; Gutiérrez-Junquerae, Carolina (ELSEVIER SCIENCE INC, 2026-11)
    BACKGROUND: Real-world paediatric data on dupilumab for eosinophilic esophagitis are scarce. AIMS: To assess the effectiveness and safety of dupilumab in children and adolescents with eosinophilic esophagitis in routine ...
  • Daruwalla, Cyrus; Kremler, Courtney; Patti, Francesco; Ozakbas, Serkan; Boz, Cavit; Lechner-Scott, Jeannette; Surcinelli, Andrea; Foschi, Matteo; Khoury, Samia-J; Butzkueven, Helmut; van-der-Walt, Anneke; Rous, Zuzana; Habek, Mario; Meca-Lallana, José-Eustasio; López, Gabriel-Valero; Alroughani, Raed; Blanco, Yolanda; Laureys, Guy; Skibina, Olga; Buzzard, Katherine; Gray, Orla; McCombe, Pamela; Maimone, Davide; Duquette, Pierre; Girard, Marc; Prat, Alexandre; Sánchez-Menoyo, José-Luis; van-Pesch, Vincent; Soysal, Aysun; Amato, María-Pia; Grand'Maison, Francois; Wilton, Judith; Van-Wijmeersch, Bart; Gerlach, Oliver; Lugaresi, Alessandra; Tomassini, Valentina; De-Luca, Giovanna; Taylor, Bruce; Foong, Yi-Chao; John, Nevin; Cardenas-Robledo, Simon; Hodgkinson, Suzanne; Macdonell, Richard; Willekens, Barbara; Garber, Justin; D'Amico, Emanuele; Terzi, Murat; Houskova, Jana; Lapointe, Emmanuelle; Al-Asmi, Abdullah; Barnett, Michael; Stetkarova, Ivana; Gouider, Riadh; Mrabet, Saloua; Csepany, Tunde; McGuigan, Chris; Gross-Paju, Katrin; Kuhle, Jens; Castillo-Trivino, Tamara; Kerrigan, Simon; Tolkovsky, Aviva-M; Wardle, Mark; Cunniffe, Nick-G; Roos, Izanne; Madley-Dowd, Paul; Coles, Alasdair; Kalincik, Tomas; Sterne, Jonathan-A-C; William-Brown, J-L (OXFORD UNIVERSITY PRESS (OUP), 2026-07-24)
    Clinically silent MRI lesions occur frequently in people with relapsing-remitting multiple sclerosis (RRMS) despite disease modifying therapy (DMT). Guidelines only routinely recommend DMT escalation after multiple silent ...
  • de-Rojas, Itziar; García-González, Pablo; Olive, Claudia; Puerta, Raquel; Montrreal, Laura; Alegret, Montserrat; Sotolongo-Grau, Oscar; Cano, Amanda; Marquie, Marta; Valero, Sergi; Calero, Miguel; Rabano, Alberto; Pastor, Ana-Bélen; del-Ser, Teodoro; Quintela, Ines; Macias, Juan; Corma-Gomez, Anais; Pineda, Juan-A; Franco-Macias, Emilio; Buiza-Rueda, Dolores; Bernal-Sánchez-Arjona, María; Royo, José-Luis; Mendoza, Silvia; Lage, Carmen; Antúnez-Almagro, Carmen; Corbaton-Anchuelo, Arturo; Martínez-Larrad, María-Teresa; Diez-Fairen, Monica; Álvarez, Ignacio; Huerto-Vilas, Raquel; Arias-Pastor, Alfonso; Menendez-González, Manuel; Martínez-Rodríguez, Carmen; Rosas-Allende, Irene; García-Madrona, Sebastian; Frank-García, Ana; Martin-Montes, Angel; Baquero, Miquel; Vargas, Liliana; Vivancos-Moreau, Laura; Pérez-Tur, Jordi; Bullido, María-J; García-Ribas, Guillermo; Álvarez, Victoria; Pinol-Ripoll, Gerard; Pastor, Pau; Rodríguez-Rodríguez, Eloy; García-Alberca, José-María; Mir, Pablo; Real, Luis-M; Medina, Miguel; Saez, María-Eugenia; Carracedo, Angel; Heneka, Michael-T; Tarraga, Lluis; Boada, Merce; Sánchez-Juan, Pascual; Fernández, M-Victoria; van-der-Lee, Sven-J; Ruiz, Agustin (NATURE PORTFOLIO, 2026-06-30)
    Recent studies suggest that copy number variants (CNVs) may contribute to the missing heritability of complex diseases such as Alzheimer's disease (AD) and related dementias (ADRD). We performed a CNV analysis using ...
  • De-Paz-Arias, R; Maortua-Langdon, G; Stuckey, R; Giraldo, P; Xicoy, B; Martínez-López, J; Bautista, G; Alonso-Alonso, J-M; Noya, M-S; Sierra, M; de-las-Heras, N; Pérez-López, Raúl; Saavedra, S; Gómez-García-de-Soria, V; Chen-Liang, Tzu-Hua; Santaliestra, Marta; García-Gutiérrez, V (SPRINGER, 2026-08-01)
    Treatment-free remission (TFR) is an established therapeutic goal for patients with chronic myeloid leukemia (CML) achieving sustained deep molecular response (DMR) on tyrosine kinase inhibitors (TKIs). However, evidence ...

Más